The "Towards a Revolution in COPD Health" study: Comparing treatment strategies

Affiliations

Comment

Anthony D D'Urzo. Can Fam Physician. 2008 May.

. 2008 May;54(5):740-1.

¹ Department of Family and Community Medicine at the University of Toronto in Ontario.

No abstract available

Comment on

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Calverley PM, et al. N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070. N Engl J Med. 2007. PMID: 17314337 Clinical Trial.

1. O’Donnell DE, Hernandez P, Aaron S, Bourbeau J, Marciniuk D, Hodder R, et al. Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors. CanResp J. 2003;10(4):183–5. - PubMed
1. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. AnnIntern Med. 2005;142(4):233–9. - PubMed
1. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N EnglJ Med. 2003;348(21):2059–73. Epub 2003 May 20. - PubMed
1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. AnnIntern Med. 1980;93(3):391–8. - PubMed
1. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005;60(12):992–7. Epub 2005 Oct 14. - PMC - PubMed